ACRS
Aclaris Therapeutics, Inc.$4.47+0.25 (+5.92%)Prev Close$4.22·MCap$518.6M·P/E—·Vol1.10M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
10
$1.76M
◆
Net Activity
Net Seller
$1.76M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Aclaris Therapeutics, Inc. (ACRS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $1.76M. The most recent insider transaction was by Leonard Braden Michael (10 percent owner), who sold $1.36M worth of shares on Apr 27, 2026. Aclaris Therapeutics, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $518.6M.
ACRS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Leonard Braden Michael | 10 percent owner | Sell | 300,000 | $4.53 | $1.36M | 13,950,000 |
| Feb 3, 2026 | Balthaser Kevin | Chief Financial Officer | Sell | 6,449 | $3.47 | $22.4K | 0 |
| Feb 3, 2026 | Loerop James | Chief Business Officer | Sell | 5,937 | $3.47 | $20.6K | 0 |
| Feb 3, 2026 | Walker Neal | CEO | Sell | 18,611 | $3.47 | $64.6K | 0 |
| Feb 1, 2026 | Balthaser Kevin | Chief Financial Officer | Sell | 4,984 | $3.51 | $17.5K | 0 |
| Feb 1, 2026 | Loerop James | Chief Business Officer | Sell | 15,980 | $2.48 | $39.6K | 0 |
| Jan 2, 2026 | Walker Neal | CEO | Sell | 9,952 | $2.88 | $28.7K | 0 |
| Dec 31, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 26,645 | $2.99 | $79.6K | 0 |
| Dec 31, 2025 | Loerop James | Chief Business Officer | Sell | 40,165 | $2.99 | $120.1K | 0 |
| May 1, 2025 | Walker Neal | CEO | Sell | 2,975 | $1.38 | $4.1K | 0 |
| Apr 1, 2025 | Walker Neal | CEO | Sell | 3,042 | $1.48 | $4.5K | 0 |
| Mar 1, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 727 | $1.99 | $1.4K | 0 |
| Mar 1, 2025 | Monahan Joseph | Chief Scientific Officer | Sell | 27,258 | $1.99 | $54.2K | 0 |
| Mar 1, 2025 | Walker Neal | CEO | Sell | 3,277 | $1.99 | $6.5K | 0 |
| Feb 1, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 5,816 | $2.48 | $14.4K | 0 |
| Feb 1, 2025 | Loerop James | Chief Business Officer | Sell | 15,447 | $2.48 | $38.3K | 0 |
| Feb 1, 2025 | Monahan Joseph | Chief Scientific Officer | Sell | 11,317 | $2.48 | $28.1K | 0 |
| Feb 1, 2025 | Walker Neal | INTERIM CEO | Sell | 3,559 | $2.48 | $8.8K | 0 |
| Jan 1, 2025 | Walker Neal | INTERIM CEO | Sell | 17,436 | $2.48 | $43.2K | 0 |
| Dec 31, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 38,221 | $2.48 | $94.8K | 0 |
| Dec 31, 2024 | Loerop James | Chief Business Officer | Sell | 40,664 | $2.48 | $100.8K | 0 |
| Dec 4, 2024 | Walker Neal | INTERIM CEO | Sell | 68,343 | $3.76 | $257.0K | 0 |
| Dec 1, 2024 | Walker Neal | INTERIM CEO | Sell | 2,721 | $4.07 | $11.1K | 0 |
| Nov 19, 2024 | Mehra Anand | Director | Buy | 666,666 | $2.25 | $1.50M0.6% OS | 0 |
| Nov 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,721 | $2.09 | $5.7K | 0 |
| Oct 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Sep 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 286 | $1.18 | $337.48 | 0 |
| Sep 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Aug 2, 2024 | Leonard Braden Michael | 10% Owner | Buy | 373,569 | $1.27 | $472.8K | 0 |
| Aug 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.32 | $3.6K | 0 |
| Jul 30, 2024 | Leonard Braden Michael | 10% Owner | Buy | 273,730 | $1.31 | $359.0K | 0 |
| Jul 18, 2024 | Leonard Braden Michael | 10% Owner | Buy | 154,722 | $1.30 | $201.8K | 0 |
| Jul 2, 2024 | Leonard Braden Michael | 10% Owner | Buy | 352,397 | $1.15 | $405.9K | 0 |
| Jul 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.15 | $3.1K | 0 |
| Jun 27, 2024 | Leonard Braden Michael | 10% Owner | Buy | 1,543,434 | $1.13 | $1.74M1.3% OS | 0 |
| Jun 14, 2024 | Leonard Braden Michael | 10% Owner | Buy | 545,000 | $1.15 | $628.2K | 0 |
| Jun 11, 2024 | Leonard Braden Michael | 10% Owner | Buy | 1,611,200 | $1.11 | $1.78M1.3% OS | 0 |
| Jun 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.03 | $2.8K | 0 |
| May 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,784 | $1.26 | $3.5K | 0 |
| Apr 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 3,224 | $1.26 | $4.1K | 0 |
| Mar 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 1,417 | $1.24 | $1.8K | 0 |
| Mar 1, 2024 | Monahan Joseph | Chief Scientific Officer | Sell | 21,283 | $1.24 | $26.4K | 0 |
| Mar 1, 2024 | Powell Andrew Kenneth William | Director | Buy | 14,500 | $1.24 | $18.0K | 0 |
| Mar 1, 2024 | Walker Neal | Interim President and CEO | Sell | 3,223 | $1.24 | $4.0K | 0 |
| Feb 1, 2024 | Loerop James | Chief Business Officer | Sell | 6,421 | $1.20 | $7.7K | 0 |
| Feb 1, 2024 | Monahan Joseph | Chief Scientific Officer | Sell | 2,583 | $1.20 | $3.1K | 0 |
| Jan 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 2,536 | $1.05 | $2.7K | 0 |
| Jan 1, 2024 | Manion Douglas J. | Pres and CEO | Sell | 9,125 | $1.05 | $9.6K | 0 |
| Oct 23, 2023 | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30.5K | 0 |
| Sep 6, 2023 | Balthaser Kevin | Chief Financial Officer | Buy | 9,490 | $7.90 | $75.0K | 0 |
Showing 1–50 of 96
1 / 2
ACRS Insider Buying Activity
The following table shows recent insider purchases of Aclaris Therapeutics, Inc. (ACRS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | Mehra Anand | Director | Buy | 666,666 | $2.25 | $1.50M0.6% OS | 0 |
| Aug 2, 2024 | Leonard Braden Michael | 10% Owner | Buy | 373,569 | $1.27 | $472.8K | 0 |
| Jul 30, 2024 | Leonard Braden Michael | 10% Owner | Buy | 273,730 | $1.31 | $359.0K | 0 |
| Jul 18, 2024 | Leonard Braden Michael | 10% Owner | Buy | 154,722 | $1.30 | $201.8K | 0 |
| Jul 2, 2024 | Leonard Braden Michael | 10% Owner | Buy | 352,397 | $1.15 | $405.9K | 0 |
| Jun 27, 2024 | Leonard Braden Michael | 10% Owner | Buy | 1,543,434 | $1.13 | $1.74M1.3% OS | 0 |
| Jun 14, 2024 | Leonard Braden Michael | 10% Owner | Buy | 545,000 | $1.15 | $628.2K | 0 |
| Jun 11, 2024 | Leonard Braden Michael | 10% Owner | Buy | 1,611,200 | $1.11 | $1.78M1.3% OS | 0 |
| Mar 1, 2024 | Powell Andrew Kenneth William | Director | Buy | 14,500 | $1.24 | $18.0K | 0 |
| Sep 6, 2023 | Balthaser Kevin | Chief Financial Officer | Buy | 9,490 | $7.90 | $75.0K | 0 |
ACRS Insider Selling Activity
The following table shows recent insider sales of Aclaris Therapeutics, Inc. (ACRS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Leonard Braden Michael | 10 percent owner | Sell | 300,000 | $4.53 | $1.36M | 13,950,000 |
| Feb 3, 2026 | Balthaser Kevin | Chief Financial Officer | Sell | 6,449 | $3.47 | $22.4K | 0 |
| Feb 3, 2026 | Loerop James | Chief Business Officer | Sell | 5,937 | $3.47 | $20.6K | 0 |
| Feb 3, 2026 | Walker Neal | CEO | Sell | 18,611 | $3.47 | $64.6K | 0 |
| Feb 1, 2026 | Balthaser Kevin | Chief Financial Officer | Sell | 4,984 | $3.51 | $17.5K | 0 |
| Feb 1, 2026 | Loerop James | Chief Business Officer | Sell | 15,980 | $2.48 | $39.6K | 0 |
| Jan 2, 2026 | Walker Neal | CEO | Sell | 9,952 | $2.88 | $28.7K | 0 |
| Dec 31, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 26,645 | $2.99 | $79.6K | 0 |
| Dec 31, 2025 | Loerop James | Chief Business Officer | Sell | 40,165 | $2.99 | $120.1K | 0 |
| May 1, 2025 | Walker Neal | CEO | Sell | 2,975 | $1.38 | $4.1K | 0 |
| Apr 1, 2025 | Walker Neal | CEO | Sell | 3,042 | $1.48 | $4.5K | 0 |
| Mar 1, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 727 | $1.99 | $1.4K | 0 |
| Mar 1, 2025 | Monahan Joseph | Chief Scientific Officer | Sell | 27,258 | $1.99 | $54.2K | 0 |
| Mar 1, 2025 | Walker Neal | CEO | Sell | 3,277 | $1.99 | $6.5K | 0 |
| Feb 1, 2025 | Balthaser Kevin | Chief Financial Officer | Sell | 5,816 | $2.48 | $14.4K | 0 |
| Feb 1, 2025 | Loerop James | Chief Business Officer | Sell | 15,447 | $2.48 | $38.3K | 0 |
| Feb 1, 2025 | Monahan Joseph | Chief Scientific Officer | Sell | 11,317 | $2.48 | $28.1K | 0 |
| Feb 1, 2025 | Walker Neal | INTERIM CEO | Sell | 3,559 | $2.48 | $8.8K | 0 |
| Jan 1, 2025 | Walker Neal | INTERIM CEO | Sell | 17,436 | $2.48 | $43.2K | 0 |
| Dec 31, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 38,221 | $2.48 | $94.8K | 0 |
| Dec 31, 2024 | Loerop James | Chief Business Officer | Sell | 40,664 | $2.48 | $100.8K | 0 |
| Dec 4, 2024 | Walker Neal | INTERIM CEO | Sell | 68,343 | $3.76 | $257.0K | 0 |
| Dec 1, 2024 | Walker Neal | INTERIM CEO | Sell | 2,721 | $4.07 | $11.1K | 0 |
| Nov 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,721 | $2.09 | $5.7K | 0 |
| Oct 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Sep 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 286 | $1.18 | $337.48 | 0 |
| Sep 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Aug 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.32 | $3.6K | 0 |
| Jul 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.15 | $3.1K | 0 |
| Jun 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.03 | $2.8K | 0 |
| May 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,784 | $1.26 | $3.5K | 0 |
| Apr 1, 2024 | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 3,224 | $1.26 | $4.1K | 0 |
| Mar 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 1,417 | $1.24 | $1.8K | 0 |
| Mar 1, 2024 | Monahan Joseph | Chief Scientific Officer | Sell | 21,283 | $1.24 | $26.4K | 0 |
| Mar 1, 2024 | Walker Neal | Interim President and CEO | Sell | 3,223 | $1.24 | $4.0K | 0 |
| Feb 1, 2024 | Loerop James | Chief Business Officer | Sell | 6,421 | $1.20 | $7.7K | 0 |
| Feb 1, 2024 | Monahan Joseph | Chief Scientific Officer | Sell | 2,583 | $1.20 | $3.1K | 0 |
| Jan 1, 2024 | Balthaser Kevin | Chief Financial Officer | Sell | 2,536 | $1.05 | $2.7K | 0 |
| Jan 1, 2024 | Manion Douglas J. | Pres and CEO | Sell | 9,125 | $1.05 | $9.6K | 0 |
| Oct 23, 2023 | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30.5K | 0 |
ACRS Insiders
Similar Stocks to ACRS
TMO
Thermo Fisher Scientific Inc.
$465.44-1.04%
$174.74B
DHR
Danaher Corporation
$178.93-0.03%
$126.68B
IDXX
IDEXX Laboratories, Inc.
$549.83-3.19%
$45.25B
NTRA
Natera, Inc.
$195.12-2.52%
$28.37B
IQV
IQVIA Holdings Inc.
$156.61-1.55%
$26.98B
MTD
Mettler-Toledo International Inc.
$1240.28-1.76%
$26.92B
DGX
Quest Diagnostics Incorporated
$189.19-3.01%
$22.69B
LH
Labcorp Holdings Inc.
$256.08-1.34%
$22.53B